These data not only show functional conservation of PLA2G6 throughout evolution but also suggest that introducing human PLA2G6 into INAD mice or INAD/PARK14 patients may alleviate the progression of the disease. This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.